Covered recipient · General Payments record
ZEKE NICHOLS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$420.14
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $247.90 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $153.54 | 3 |
| GlaxoSmithKline, LLC. | $40.60 | 2 |
| Novo Nordisk AS | $38.01 | 2 |
| ITI, Inc. | $15.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.99 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104553614 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.29 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104431167 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.26 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104261079 | CMS |
| GlaxoSmithKline, LLC. | $24.71 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116337035 | CMS |
| GlaxoSmithKline, LLC. | $15.89 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116073500 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.75 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287314 | CMS |
| Novo Nordisk Inc | $21.92 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096601041 | CMS |
| Novo Nordisk Inc | $16.09 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096968179 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.